Hikma Pharmaceutical | HIK - Interest Expense On Debt


Hikma Pharmaceutical reported $67M in Interest Expense on Debt for its fiscal semester ending in December of 2025.





Interest Expense On Debt Change Date
argenx SE USD 828K 165K Dec/2025
AstraZeneca USD 484M 181M Dec/2025
Autolus Therapeutics Ltd USD 10.52M 17.35M Sep/2025
Bayer EUR 675M 87M Dec/2025
Fresenius EUR 81M 5M Sep/2025
Galapagos EUR 1.72M 940K Sep/2025
Genmab DKK 10M 27M Dec/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 67M 47M Dec/2025
Lonza CHF 84M 14M Jun/2025
Merck EUR 121M 5M Dec/2025
Orion EUR 600K 600K Sep/2025
Recordati EUR 22.13M 1.43M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR -25M 252M Dec/2025
UCB EUR 49M 29M Dec/2025